Certificate number:RU.77.99.88.003.Е.006495.12.16
Date of registration and renewal:21.12.2016
Dosage form: & nbspTablets weighing 280 mg.
Classification "Composition" & nbsp Other dietary supplements Supplements - vitamins, vitamin-like substances and coenzymes
Classification "Clinical" & nbsp Supplements supporting the functions of the musculoskeletal system BAD-source of monovitamins and vitamin-like substances
Composition: & nbspE460, E464, E553b, E468, cholecalciferol (vitamin D3), E551, E171, E470b, E1521.
Scope: & nbspDFor sale to the population as a biologically active food additive - an additional source of vitamin D3.
Suggested Usage: & nbspAT1 tablet once a day with meals. Duration of admission is 1-2 months. After a break of 1 month, a second appointment is possible.
Contraindications:ANDindividual intolerance of components, pregnancy, breast-feeding.
Special instructions: Before use, consult a physician.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children, at a temperature not exceeding + 25 ° С.
Research protocols:In exchange for the certificate of state registration No. RU.77.99.88.003.Е.008713.08.15 of 28.08.2015, the expert opinion of the FBUC of the Federal Service for Supervision of Consumer Rights Protection of the Russian Federation No. 10-2FTS / 2004 of 20.05.2015.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp17.01.2017
Instructions
Up